Intravascular Lithotripsy for the Treatment of Calcified Coronary Artery Disease: A Simple and Disruptive Technology
- PMID: 33069848
- DOI: 10.1016/j.jacc.2020.10.014
Intravascular Lithotripsy for the Treatment of Calcified Coronary Artery Disease: A Simple and Disruptive Technology
Keywords: calcification; coronary artery disease; intravascular lithotripsy.
Conflict of interest statement
Author Disclosures Dr. Généreux has served as a consultant for Abiomed, Boston Scientific, Cardiovascular System Inc., Cordis, Edwards Lifesciences, Medtronic, Opsens, Pi-Cardia, Soundbite Medical Solutions Inc., Saranas, Siemens, Shockwave Medical Inc., SIG.NUM, Teleflex, and 4C Medical; and is a shareholder in Soundbite Medical Solutions Inc., SIG.NUM, and Puzzle Medical.
Comment on
-
Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease.J Am Coll Cardiol. 2020 Dec 1;76(22):2635-2646. doi: 10.1016/j.jacc.2020.09.603. Epub 2020 Oct 15. J Am Coll Cardiol. 2020. PMID: 33069849 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical